Evidence map›Paper›PMID 29016309›Full record

ArticleThe American journal of tropical medicine and hygiene2017

Comparative Prevalence of

Melissa D Conrad, Daniel Mota, Alex Musiime, Maxwell Kilama, John Rek, Moses Kamya, Grant Dorsey, Philip J Rosenthal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The American journal of tropical medicine and hygiene · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melissa D ConradDepartment of Medicine, University of California, San Francisco, California.
Daniel MotaDepartment of Medicine, University of California, San Francisco, California.
Alex MusiimeInfectious Disease Research Collaboration, Kampala, Uganda.
Maxwell KilamaInfectious Disease Research Collaboration, Kampala, Uganda.
John RekInfectious Disease Research Collaboration, Kampala, Uganda.
Moses KamyaMakerere University College of Health Sciences, Kampala, Uganda.
Grant DorseyDepartment of Medicine, University of California, San Francisco, California.
Philip J RosenthalDepartment of Medicine, University of California, San Francisco, California.

Funding

University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
Resistance of Malaria Parasites to Artemisinin-Based TherapiesR01AI075045 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 2009 to 2024
$8.4M
University of California Global Health Institute Program for Fellows and ScholarsR25TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, CRAIG R, STRATHDEE, STEFFANIE A. · 2012 to 2017
$6.4M
SF BUILD: Enabling Students to Represent in ScienceTL4GM118986 · NIGMS · SAN FRANCISCO STATE UNIVERSITY · PI MARQUEZ-MAGANA, LETICIA MARIA, MORRIS, MEGHAN D · 2015 to 2022
$5.4M
Resistance of Malaria Parasites to Artemisinin-Based Combination TherapiesR56AI075045 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 2008 to 2008
$618k
SF BUILD: Enabling Students to Represent in ScienceTL4MD009638 · NIMHD · SAN FRANCISCO STATE UNIVERSITY · PI BEN-ZEEV, AVI, BIBBINS-DOMINGO, KIRSTEN · 2014 to 2014
$474k
FIC NIH HHS D43 TW009343FIC NIH HHS R25 TW009343NIAID NIH HHS R01 AI075045NIAID NIH HHS R56 AI075045NIGMS NIH HHS TL4 GM118986NIMHD NIH HHS TL4 MD009638
6 · The paper itself

Abstract

Controlling malaria in high transmission areas, such as much of sub-Saharan Africa, will require concerted efforts to slow the spread of drug resistance and to impede malaria transmission. Understanding the fitness costs associated with the development of drug resistance, particularly within the context of transmission, can help guide policy decisions to accomplish these goals, as fitness constraints might lead to decreased transmission of drug-resistant strains. To determine if

Indexed as

Polymorphism, GeneticAllelesAnimalsAnophelesATP-Binding Cassette, Sub-Family C ProteinsChildChild, PreschoolDNA, ProtozoanDrug ResistanceFemaleGenotyping TechniquesHumansInfantMalaria, FalciparumMaleMembrane Transport ProteinsATP-Binding Cassette, Sub-Family C ProteinsDNA, ProtozoanMdr1 protein, Plasmodium falciparumMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID29016309
PMCPMC5817777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.